Refining the Na V 1 .7 pharmacophore of a class of venom‐derived peptide inhibitors via a combination of in silico screening and rational engineering
FEBS Letters · 2025-06 · 599 (12) · 1717-1732
DOI: 10.1002/1873-3468.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 29.03.2025. Verfasst von Gagan Sharma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Australia. Hauptthemen laut MEDLINE: NAV1.7 Voltage-Gated Sodium Channel, Peptides, Voltage-Gated Sodium Channel Blockers, Scorpion Venoms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, University of Queensland.
Abstract (Originalsprache)
Ion channels are among the main targets of venom peptides. Extensive functional screening has identified a number of these peptides as modulators of the voltage‐gated sodium channel subtype Na V 1.7, a potential target for the treatment of chronic pain. In this study, we used a bioinformatic approach that can automatically identify Na V 1.7 gating modifier toxins from sequence information alone. The method further enables the incorporation of evolutionarily accessible sequence space in structure–activity relationship studies. The in silico method identified a putative Na V 1.7 inhibitor, μ‐theraphotoxin Cg4a, which we produced recombinantly and confirmed as a Na V 1.7 inhibitor. Using structural and mutagenesis studies, we propose an improved definition of the pharmacophore of this class of Na V 1.7 inhibitors, aiding future in silico screening and classification of Na V 1.7 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Australia.
- Institute for Molecular Bioscience, The University of Queensland, St Lucia, Australia.
- Department of Biochemistry, National University of Singapore, Singapore.
- Centre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, Norway.
- The School of Pharmacy, The University of Queensland, Brisbane, Australia.
ORCID-Profile: Jennifer R Deuis, Mehdi Mobli
Förderung
- Australian Research Council
- National Health and Medical Research Council
- University of Queensland
- European Research Council
- H2020 European Research Council
Zitieren
APA
Sharma, G., Deuis, J. R., Jia, X., Crawford, T., Rahnama, S., Undheim, E. A. B., Vetter, I., Chin, Y. K., & Mobli, M. (2025). Refining the Na V 1 .7 pharmacophore of a class of venom‐derived peptide inhibitors via a combination of in silico screening and rational engineering. FEBS Letters, 599(12), 1717-1732. https://doi.org/10.1002/1873-3468.70036
Vancouver
Sharma G, Deuis JR, Jia X, Crawford T, Rahnama S, Undheim EAB, et al. Refining the Na V 1 .7 pharmacophore of a class of venom‐derived peptide inhibitors via a combination of in silico screening and rational engineering. FEBS Letters. 2025;599(12):1717-1732. doi:10.1002/1873-3468.70036
BibTeX
@article{Sharma2025,
author = {Sharma, Gagan and Deuis, Jennifer R and Jia, Xinying and Crawford, Theo and Rahnama, Sassan and Undheim, Eivind A B and Vetter, Irina and Chin, Yanni K-Y and Mobli, Mehdi},
title = {Refining the Na V 1 .7 pharmacophore of a class of venom‐derived peptide inhibitors via a combination of in silico screening and rational engineering},
journal = {FEBS Letters},
year = {2025},
volume = {599},
number = {12},
pages = {1717--1732},
doi = {10.1002/1873-3468.70036}
}
EUVIMED